Depressive symptoms are associated with visceral adiposity in a community-based sample of middle-aged women and men

Obesity

Volumn 21, Issue 8, 2013, Pages 1713-1719

  Murabito, Joanne M ^a,b   Massaro, Joseph M ^c   Clifford, Brian ^a   Hoffmann, Udo ^d   Fox, Caroline S ^b,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c USA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHOLESTEROL BLOOD LEVEL; COMMUNITY SAMPLE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OBESITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING; SUBCUTANEOUS FAT;

ADIPOSITY; ADULT; ANTIDEPRESSIVE AGENTS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MENOPAUSE; MIDDLE AGED; MOTOR ACTIVITY; RISK FACTORS; SUBCUTANEOUS FAT;

EID: 84883161905     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20130     Document Type: Article

References (34)

1. Ferketich AK, Schwartzbaum JA, Frid DJ, et al. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med 2000; 160: 1261-1268.
2. Wassertheil-Smoller S, Shumaker S, Ockene J, et al. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med 2004; 164: 289-298.
3. Mezuk B, Eaton WW, Albrecht S, et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31: 2383-2390.
4. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-229.
5. Williams LJ, Pasco JA, Henry MJ, et al. Lifetime psychiatric disorders and body composition: a population-based study. J Affect Disord 2009; 118: 173-179.
6. Vogelzangs N, Kritchevsky SB, Beekman AT, et al. Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 2008; 65: 1386-1393.
7. Vogelzangs N, Kritchevsky SB, Beekman AT, et al. Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry 2010; 71: 391-399.
8. Weber-Hamann B, Werner M, Hentschel F, et al. Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 2006; 31: 347-354.
9. Everson-Rose SA, Lewis TT, Karavolos K, et al. Depressive symptoms and increased visceral fat in middle-aged women. Psychosom Med 2009; 71: 410-416.
10. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
11. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007; 116: 1234-1241.
12. Kannel WB, Feinleib M, McNamara PM, et al. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979; 110: 281-290.
13. Splansky GL, Corey D, Yang Q, et al. The third generation cohort of the national heart, lung, and blood institute's Framingham heart study: design, recruitment, and initial examination. Am J Epidemiol 2007; 165: 1328-1335.
14. Maurovich-Horvat P, Massaro J, Fox CS, et al. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 2007; 31: 500-506.
15. National Center for Health Statistics: Basic Data on Depressive Symptomatology United States, 1974-75. DHEW Publication No (PHS) 80-1666. US Department of Health, Education and Welfare. 1980.
16. Survival following initial cardiovascular disease events: 30 year follow-up. In:, Kannel WB, Wolf PA, Garrison RJ, editors. The Framingham Heart Study: an epidemiological investigation of cardiovascular disease. Bethesda, MD: NHLBI, NIH; 1988, p. 1-12.
17. Levy D, DeStefano AL, Larson MG, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension 2000; 36: 477-483.
18. Matthews KA, Schott LL, Bromberger JT, et al. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women? Brain Behav Immun 2010; 24: 96-101.
19. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
20. Tran TT, Yamamoto Y, Gesta S, et al. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008; 7: 410-420.
21. Porter SA, Massaro JM, Hoffmann U, et al. Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 2009; 32: 1068-1075.
22. Ma J, Xiao L,. Obesity and depression in US women: results from the 2005-2006 National Health and Nutritional Examination Survey. Obesity (Silver Spring) 2010; 18: 347-353.
23. Rivenes AC, Harvey SB, Mykletun A,. The relationship between abdominal fat, obesity, and common mental disorders: results from the HUNT study. J Psychosom Res 2009; 66: 269-275.
24. Beydoun MA, Kuczmarski MT, Mason MA, et al. Role of depressive symptoms in explaining socioeconomic status disparities in dietary quality and central adiposity among US adults: a structural equation modeling approach. Am J Clin Nutr 2009; 90: 1084-1095.
25. Hach I, Ruhl UE, Klotsche J, et al. Associations between waist circumference and depressive disorders. J Affect Disord 2006; 92: 305-308.
26. Lee ES, Kim YH, Beck SH, et al. Depressive mood and abdominal fat distribution in overweight premenopausal women. Obes Res 2005; 13: 320-325.
27. King GA, Fitzhugh EC, Bassett DR Jr, et al. Relationship of leisure-time physical activity and occupational activity to the prevalence of obesity. Int J Obes Relat Metab Disord 2001; 25: 606-612.
28. Blumenthal JA, Babyak MA, Moore KA, et al. Effects of exercise training on older patients with major depression. Arch Intern Med 1999; 159: 2349-2356.
29. Miller GE, Stetler CA, Carney RM, et al. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1283.
30. Lesperance F, Frasure-Smith N, Theroux P, et al. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004; 161: 271-277.
31. Penninx BW, Kritchevsky SB, Yaffe K, et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 2003; 54: 566-572.
32. Janssen I, Powell LH, Kazlauskaite R, et al. Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study. Obesity (Silver Spring) 2010; 18: 604.
33. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010; 67: 598-607.
34. Vicennati V, Pasquali R,. Abnormalities of the hypothalamic-pituitary- adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metab 2000; 85: 4093-4098.